Drugplain

Pentazocine and naloxone .5 mg/1

Pentazocine hydrochloride and naloxone hydrochloride · TABLET · Actavis Pharma, Inc.

No Recall History
Plain English

Pentazocine and naloxone is a tablet containing pentazocine hydrochloride and naloxone hydrochloride at .5 mg/1, taken oral. Manufactured by Actavis Pharma, Inc..

Key Facts

Brand Name
Pentazocine and naloxone
Generic Name
Pentazocine hydrochloride and naloxone hydrochloride
NDC Code (Product)
0591-0395
Manufacturer
Actavis Pharma, Inc.
Strength
.5 mg/1
Dosage Form
TABLET
Route
ORAL
Marketing Status
DEA Schedule
Schedule IV (Controlled)
Application #
ANDA074736
Marketing Start
05/21/1997

Recall History

No Recall History

Frequently Asked Questions

What is Pentazocine and naloxone used for?

Pentazocine and naloxone contains Pentazocine hydrochloride and naloxone hydrochloride. It is a tablet taken oral. Consult your doctor for specific uses.

Is Pentazocine and naloxone a controlled substance?

Yes, Pentazocine and naloxone is classified as CIV under the DEA Controlled Substances Act.

What is the generic name for Pentazocine and naloxone?

The generic name for Pentazocine and naloxone is Pentazocine hydrochloride and naloxone hydrochloride. There are 1 other brand versions of Pentazocine hydrochloride and naloxone hydrochloride.

What is the NDC code for Pentazocine and naloxone .5 mg/1?

The NDC (National Drug Code) for Pentazocine and naloxone .5 mg/1 is 0591-0395, listed by Actavis Pharma, Inc..

Product NDC

0591-0395

Package NDC

0591-0395-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)